| Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity RA Kemp, F Ronchese The Journal of Immunology 167 (11), 6497-6502, 2001 | 191 | 2001 |
| Gene microarrays reveal extensive differential gene expression in both CD4+ and CD8+ type 1 and type 2 T cells T Chtanova, RA Kemp, APR Sutherland, F Ronchese, CR Mackay The Journal of Immunology 167 (6), 3057-3063, 2001 | 175 | 2001 |
| Regulatory T‐cell heterogeneity and the cancer immune response KA Ward‐Hartstonge, RA Kemp Clinical & translational immunology 6 (9), e154, 2017 | 128 | 2017 |
| Tertiary lymphoid structures in cancer–considerations for patient prognosis L Munoz-Erazo, JL Rhodes, VC Marion, RA Kemp Cellular & molecular immunology 17 (6), 570-575, 2020 | 116 | 2020 |
| Repeated stimulation of CD4 effector T cells can limit their protective function DM Jelley-Gibbs, JP Dibble, S Filipson, L Haynes, RA Kemp, SL Swain The Journal of experimental medicine 201 (7), 1101-1112, 2005 | 116 | 2005 |
| Activation of the NLRP3 inflammasome is not a feature of all particulate vaccine adjuvants S Neumann, K Burkert, R Kemp, T Rades, P Rod Dunbar, S Hook Immunology and Cell Biology 92 (6), 535-542, 2014 | 83 | 2014 |
| Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems S Gordon, K Young, R Wilson, S Rizwan, R Kemp, T Rades, S Hook Journal of liposome research 22 (3), 193-204, 2012 | 68 | 2012 |
| Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo DS Ritchie, IF Hermans, JM Lumsden, CB Scanga, JM Roberts, J Yang, ... Journal of immunological methods 246 (1-2), 109-117, 2000 | 67 | 2000 |
| CD8+ T cells responding to influenza infection reach and persist at higher numbers than CD4+ T cells independently of precursor frequency TJ Powell, DM Brown, JA Hollenbaugh, T Charbonneau, RA Kemp, ... Clinical immunology 113 (1), 89-100, 2004 | 63 | 2004 |
| Cutting edge: regulation of CD8+ T cell effector population size RA Kemp, TJ Powell, DW Dwyer, RW Dutton The Journal of Immunology 173 (5), 2923-2927, 2004 | 61 | 2004 |
| Intestinal organoids as a tool for inflammatory bowel disease research HCK Angus, AG Butt, M Schultz, RA Kemp Frontiers in medicine 6, 334, 2020 | 55 | 2020 |
| The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity RA Kemp, BT Bäckström, F Ronchese Immunology 115 (3), 315-324, 2005 | 50 | 2005 |
| Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients A Girardin, J McCall, MA Black, F Edwards, V Phillips, ES Taylor, ... International journal of cancer 132 (8), 1842-1850, 2013 | 47 | 2013 |
| Gut macrophage phenotype is dependent on the tumor microenvironment in colorectal cancer SE Norton, ETJ Dunn, JL McCall, F Munro, RA Kemp Clinical & translational immunology 5 (4), e76, 2016 | 42 | 2016 |
| Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma AJ Highton, T Kojarunchitt, A Girardin, S Hook, RA Kemp Immunology and cell biology 93 (7), 634-640, 2015 | 42 | 2015 |
| Survival of Listeria monocytogenes in sea water and effect of exposure on thermal resistance PJ Bremer, CM Osborne, RA Kemp, JJ Smith Journal of applied microbiology 85 (3), 545-553, 1998 | 39 | 1998 |
| The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor‐infiltrating T cells A Lepletier, VP Lutzky, D Mittal, K Stannard, TS Watkins, CN Ratnatunga, ... Immunology and cell biology 97 (2), 152-164, 2019 | 38 | 2019 |
| Thermal death times of Hafnia alvei cells in a model suspension and in artificially contaminated hot-smoked kahawai (Arripis trutta) PJ Bremer, CM Osborne, RA Kemp, P van Veghel, GC Fletcher Journal of Food Protection&# 174; 61 (8), 1047-1051, 1998 | 34 | 1998 |
| Immune cell interplay in colorectal cancer prognosis SE Norton, KA Ward-Hartstonge, ES Taylor, RA Kemp World journal of gastrointestinal oncology 7 (10), 221, 2015 | 33 | 2015 |
| Inclusion of BLIMP-1+ effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study KA Ward-Hartstonge, JL McCall, TR McCulloch, AK Kamps, A Girardin, ... Cancer Immunology, Immunotherapy 66, 515-522, 2017 | 26 | 2017 |
Sarah HookUniversity of OtagoVerified email at otago.ac.nz
